Unusual acute promyelocytic leukemia following de novo renal transplant: Case report and literature review

Clinical Nephrology

Volumn 75, Issue SUPPL. 1, 2011, Pages

  Lai, C P ^a   Chang, C C ^a   Chung, C Y ^a   Chen, M L ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Acute promyelocytic leukemia; Isoforms; PML RAR fusion gene; Post renal transplant

Indexed keywords

CYTARABINE; IDARUBICIN; MESSENGER RNA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; RETINOIC ACID; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW BIOPSY; CADAVER KIDNEY; CASE REPORT; CHRONIC KIDNEY DISEASE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FUSION GENE; GINGIVA BLEEDING; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; KIDNEY TRANSPLANTATION; LEUKEMIA REMISSION; LEUKEMOGENESIS; MALE; MULTIPLE CYCLE TREATMENT; PML RARALPHA GENE; PROMYELOCYTIC LEUKEMIA; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW EXAMINATION; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; KIDNEY TRANSPLANTATION; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79951967486     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106521     Document Type: Article

References (28)

1. Stiasny B, Ziebell D, Graf S, Hauser IA, Schulze BD. Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol. 2002; 58: 16-24. (Pubitemid 34752989)
2. Canöz O, Soyuer I, Taskapan H, Utas C. T cell extranodal lymphoma case involving pleura and pericardium in a renal transplant patient. Clin Nephrol. 2001; 55: 416-418. (Pubitemid 32427927)
3. Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant. 1993; 12: 328-336.
4. Greer JP, Kinney MC. Acute nonlymphocytic leukemia. In: Lee RG, Bithell TC, Foerster J, Athens JW, Lukens JN (eds). Wintrobe's Clinical Hematology 2, 9th edn, Lea & Febiger: Pennsylvania; 1993. p. 1920-1945.
5. Thalhammer-Scherrer R, Wieselthaler G, Knoebl P, Schwarzinger I, Simonitsch I, Mitterbauer G, Berlakovich GA, Mannhalter C, Haas OA, Mayer G, Muehlbacher F, Wolner E, Klepetko W, Lechner K, Jaeger U. Post-transplant acute myeloid leukemia (PT-AML). Leukemia. 1999; 13: 321-326. (Pubitemid 29108069)
6. Cuthbert RJG, Russell NH, Jones PAE, Morgan AG. Treatment of acute myeloid leukaemia in a renal allograft recipient: Implications of cyclosporin immunosuppressive treatment. J Clin Pathol. 1991; 44: 693-695.
7. Specchia G, Storlazzi CT, Cuneo A, Surace C, Mestice A, Pannunzio A, Rocchi M, Liso V. Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case. Ann Hematol. 2001; 80: 246-250. (Pubitemid 32421907)
8. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913. (Pubitemid 38745589)
9. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999; 397: 530-534.
10. Sato T, Fujieda M, Maeda A, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Hattori M, Wakiguchi H. Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients. Clin Nephrol. 2008; 70: 393-403.
11. Razeghi E, Hadadi A, Khashayar P, Pourmand G. Kaposi's sarcoma in renal transplantation: report of three cases. Clin Nephrol. 2009; 71: 214-216.
12. Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, Jauch KW, Guba M. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 2007; 71: 1271-1278. (Pubitemid 46887541)
13. Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med. 2005; 352: 1371-1373. (Pubitemid 40411505)
14. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005; 352: 1317-1323. (Pubitemid 40411498)
15. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarell Ai, Coco FL, Biondi A, Grignani F, Pelicci PG. Expression pattern of the RARa-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA. 1992; 89: 4840-4844.
16. J Gabert, E Beillard, VHJ van der Velden,W Bi,D Grimwade, N Pallisgaard, G Barbany, G Cazzaniga, J M Cayuela, H Cavé, F Pane, J L E Aerts, D De Micheli, X Thirion, V Pradel, M González, S Viehmann, M Malec, G Saglio, J J M van Dongen. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program. Leukemia. 2003; 17: 2318-2357.
17. Piazza F, Gurrieri C, Pandolfi PP. The theory of APL. Oncogene. 2001; 20: 7216-7222. (Pubitemid 33105010)
18. He L-Z, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA. 1997; 94: 5302-5307. (Pubitemid 27214778)
19. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood. 1997; 89: 376-387. (Pubitemid 27051671)
20. Mitelman F. Catalog of chromosome aberrations in cancer '98. CD-ROM. 6th edn. New York:Wiley-Liss; 1998.
21. Kudo K, Yoshida H, Kiyoi H, Numata S, Horibe K, Naoe T. Etoposide- related acute promyelocytic leukemia. Leukemia. 1998; 12: 1171-1175. (Pubitemid 28395977)
22. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3: 730-737. (Pubitemid 27298715)
23. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, Macintyre EA, Varet B. Highly purified primitive hematopoietic stem cells are PML-RARα negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 1995; 85: 2154-2161.
24. Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R, Craddock CF, Linch DC, Solomon E. TheT-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. Cancer Res. 2002; 62: 4730-4735.
25. Oconnor S, Evans P, Morgan GJ. Diagnostic approaches to acute promyelocytic leukaemia. Leuk Lymphoma. 1999; 33: 53-63. (Pubitemid 29116394)
26. Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA,Warrell RP Jr. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood. 1994; 84: 3843-3849.
27. Silvergleid AJ, Schrier SL. Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases. Am J Med. 1974; 57: 885-888.
28. Specchia G, Storlazzi CT, Cuneo A, Surace C, Mestice A, Pannunzio A, Rocchi M, Liso V. Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case. Ann Hematol. 2001; 80: 246-250. (Pubitemid 32421907)